17 February 2022
: Case report 
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Sara Al-Rasbi12ABEF, Juhaina Salim Al-Maqbali3ABEFG*, Rajaa Al-Farsi2BE, Moza Ali Al Shukaili4BE, Maryam H. Al-Riyami2EF, Zubaida Al Falahi1EF, Hatem Al Farhan12AG, Abdullah M. Al Alawi12AEFGDOI: 10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
Table 2. Results summary of the hospitalization microbiology tests.
| Test | Result |
|---|---|
| Respiratory viral screen (including: Rhinovirus PCR, RSV PCR, Adenovirus RVS, Enterovirus RVS, H1N1 confirmatory PCR, Human Metapneumovirus PCR, Parechoviruses, Human Bocavirus, Influenza A and B PCR, Corona viruses 229, 63 and 43 HKU PCR, Parainfluenzae 1,2,3,4 PCR) | Negatives |
| Mycoplasma pneumonia PCR | Negative |
| Urinary antigen (Legionella) | Negative |
| Urinary antigen (pneumococcus) | Negative |
| Pneumocystis PCR | Negative |
| Cytomegalovirus serology (CMV) | Negative |
| Epstein Barr Virous Serology (EBV) | Negative |
| Toxoplasma Serology | Negative |
| HIV 1&2 Ag/Ab | Negative |
| Urine culture | Negative |
| Blood culture | Negative |
| Sputum culture | Negative |
| Mycobacterium Tuberculosis (TB) gene Expert | Negative |
| Aspergillus Galactomannan Antigen | Negative |